• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危险因素管理与心房颤动诊所:把最好的留到最后?

Risk Factor Management and Atrial Fibrillation Clinics: Saving the Best for Last?

作者信息

Mahajan Rajiv, Pathak Rajeev K, Thiyagarajah Anand, Lau Dennis H, Marchlinski Francis E, Dixit Sanjay, Day John D, Hendriks Jeroen M L, Carrington Melinda, Kalman Jonathan M, Sanders Prashanthan

机构信息

Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, Adelaide, SA, Australia.

Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, Adelaide, SA, Australia; Cardiac Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Heart Lung Circ. 2017 Sep;26(9):990-997. doi: 10.1016/j.hlc.2017.05.123. Epub 2017 Jun 9.

DOI:10.1016/j.hlc.2017.05.123
PMID:28662919
Abstract

Atrial fibrillation (AF) is a leading cause of cardiovascular morbidity and mortality worldwide. Management of AF is a complex process involving: 1) the prevention of thromboembolic complications with anticoagulation; 2) rhythm control; and 3) the detection and treatment of underlying heart disease. However, cardiometabolic risk factors, such as obesity, hypertension, diabetes mellitus, and obstructive sleep apnoea, have been proposed as contributors to the expanding epidemic of atrial fibrillation (AF). Thus, a fourth pillar of AF care would include aggressive targeting of interdependent, modifiable cardiovascular risk factors as part of an integrated care model. Such risk factor management could retard and reverse the pathological processes underlying AF and reduce AF burden.

摘要

心房颤动(AF)是全球心血管疾病发病和死亡的主要原因。房颤的管理是一个复杂的过程,包括:1)通过抗凝预防血栓栓塞并发症;2)节律控制;3)潜在心脏病的检测和治疗。然而,肥胖、高血压、糖尿病和阻塞性睡眠呼吸暂停等心脏代谢危险因素已被认为是导致心房颤动(AF)流行趋势扩大的因素。因此,房颤护理的第四大支柱将包括在综合护理模式中积极针对相互关联、可改变的心血管危险因素。这种危险因素管理可以延缓和逆转房颤潜在的病理过程,减轻房颤负担。

相似文献

1
Risk Factor Management and Atrial Fibrillation Clinics: Saving the Best for Last?危险因素管理与心房颤动诊所:把最好的留到最后?
Heart Lung Circ. 2017 Sep;26(9):990-997. doi: 10.1016/j.hlc.2017.05.123. Epub 2017 Jun 9.
2
Lifestyle modification in the prevention and treatment of atrial fibrillation.生活方式改变在心房颤动预防和治疗中的作用
Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):117-25. doi: 10.1016/j.pcad.2015.07.001. Epub 2015 Jul 13.
3
Modifiable Risk Factors and Atrial Fibrillation.可改变的风险因素与心房颤动。
Circulation. 2017 Aug 8;136(6):583-596. doi: 10.1161/CIRCULATIONAHA.116.023163.
4
Epidemiology of Atrial Fibrillation and Heart Failure: A Growing and Important Problem.心房颤动与心力衰竭的流行病学:一个日益严重且重要的问题。
Cardiol Clin. 2019 May;37(2):119-129. doi: 10.1016/j.ccl.2019.01.001. Epub 2019 Feb 22.
5
Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes.PR 间期特征预测心房颤动:与生物标志物和结局的关联。
Clin Res Cardiol. 2017 Oct;106(10):767-775. doi: 10.1007/s00392-017-1109-y. Epub 2017 Apr 5.
6
Atrial fibrillation: A review of modifiable risk factors and preventive strategies.心房颤动:可改变的危险因素及预防策略综述
Rom J Intern Med. 2019 Jun 1;57(2):99-109. doi: 10.2478/rjim-2018-0045.
7
Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation.肥胖、运动、阻塞性睡眠呼吸暂停与房颤中的可改变动脉粥样硬化性心血管疾病危险因素
J Am Coll Cardiol. 2015 Dec 29;66(25):2899-2906. doi: 10.1016/j.jacc.2015.10.047.
8
Lifestyle modifications for treatment of atrial fibrillation.生活方式的改变在房颤治疗中的作用。
Heart. 2020 Mar;106(5):325-332. doi: 10.1136/heartjnl-2019-315327. Epub 2019 Nov 11.
9
Atrial fibrillation in heart failure in the older population.老年人心力衰竭中的心房颤动。
Heart Fail Clin. 2013 Oct;9(4):451-9, viii-ix. doi: 10.1016/j.hfc.2013.07.007.
10
Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病中的心房颤动
Heart Lung Circ. 2017 Sep;26(9):975-982. doi: 10.1016/j.hlc.2017.05.116. Epub 2017 May 23.

引用本文的文献

1
Cardiovascular Imaging in the Era of Precision Medicine: Insights from Advanced Technologies - A Narrative Review.精准医学时代的心血管成像:先进技术带来的见解——一篇综述
Health Sci Rep. 2024 Oct 30;7(11):e70173. doi: 10.1002/hsr2.70173. eCollection 2024 Nov.
2
Global burden of atrial fibrillation attributable to high body mass index from 1990 to 2021: findings from the Global Burden of Disease Study 2021.全球范围内,1990 年至 2021 年因身体质量指数高导致的心房颤动负担:来自 2021 年全球疾病负担研究的结果。
BMC Cardiovasc Disord. 2024 Oct 8;24(1):542. doi: 10.1186/s12872-024-04202-5.
3
Atrial Fibrillation Health Literacy Questionnaire (AFHLQ): The development of an AF-specific health literacy questionnaire.
心房颤动健康素养问卷(AFHLQ):一种针对心房颤动的健康素养问卷的编制
Int J Cardiol Heart Vasc. 2023 Dec 21;50:101322. doi: 10.1016/j.ijcha.2023.101322. eCollection 2024 Feb.
4
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.无传统危险因素的房颤患者的特征和结局:RE-LY AF 注册分析。
Europace. 2020 Jun 1;22(6):870-877. doi: 10.1093/europace/euz360.
5
Atrial fibrillation care in rural communities: a mixed methods study of physician and patient perspectives.农村社区心房颤动护理:医生和患者观点的混合方法研究。
BMC Fam Pract. 2019 Oct 24;20(1):144. doi: 10.1186/s12875-019-1029-1.
6
Asymptomatic recurrence after AF ablation: Is all lost?房颤消融术后无症状复发:一切都无法挽回了吗?
Indian Pacing Electrophysiol J. 2017 Sep-Oct;17(5):123-124. doi: 10.1016/j.ipej.2017.08.001. Epub 2017 Aug 18.